OmniAb (OABI) EBT (2021 - 2026)
OmniAb (OABI) reported EBT of -$7.3 million for Q1 2026, up 60.31% year-over-year from -$4.5 million in Q1 2025, and up 50.05% quarter-over-quarter from -$14.5 million in Q4 2025.
OmniAb (OABI) EBT (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of EBT data on file, last reported at -$7.3 million in Q1 2026.
- EBT for Q1 2026 came in at -$7.3 million, up 60.31% year-over-year; the trailing twelve-month figure through Mar 2026 was -$55.3 million (up 18.91% YoY), and the FY2025 annual result was -$66.3 million, up 7.17% from the prior year.
- EBT grew to -$7.3 million in Q1 2026 per OABI's latest filing, from -$14.5 million in the prior quarter.
- Over five years, EBT peaked at $9.6 million in Q4 2022 and troughed at -$21.6 million in Q1 2024.
- A 5-year average of -$13.8 million and a median of -$15.5 million in 2024 frame the typical range for EBT.
- On a YoY basis, EBT climbed as much as 127.2% in 2022 and fell as far as 575002.97% in 2022.
- A 5-year view of EBT shows it stood at $9.6 million in 2022, then plunged by 307.82% to -$20.0 million in 2023, then gained by 23.99% to -$15.2 million in 2024, then rose by 4.45% to -$14.5 million in 2025, then jumped by 50.05% to -$7.3 million in 2026.
- Business Quant data shows OABI's EBT at -$7.3 million in Q1 2026, -$14.5 million in Q4 2025, and -$17.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.18 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.31 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | -7.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.27 Mn |
| Dec 31, 2025 | -14.55 Mn |
| Sep 30, 2025 | -17.69 Mn |
| Jun 30, 2025 | -15.76 Mn |
| Mar 31, 2025 | -18.31 Mn |
| Dec 31, 2024 | -15.22 Mn |
| Sep 30, 2024 | -19.08 Mn |
| Jun 30, 2024 | -15.53 Mn |
| Mar 31, 2024 | -21.58 Mn |
| Dec 31, 2023 | -20.03 Mn |
| Sep 30, 2023 | -19.04 Mn |
| Jun 30, 2023 | -18.16 Mn |
| Mar 31, 2023 | -7.13 Mn |
| Dec 31, 2022 | 9.64 Mn |
| Sep 30, 2022 | -14.91 Mn |
| Jun 30, 2022 | -12.57 Mn |
| Mar 31, 2022 | -8.22 Mn |
| Dec 31, 2021 | -35.43 Mn |
| Sep 30, 2021 | -170,579.00 |
| Jun 30, 2021 | -2,185.00 |